Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关概念视频

Peripheral Artery Disease I: Introduction01:30

Peripheral Artery Disease I: Introduction

79
Peripheral artery disease (PAD) predominantly results from atherosclerosis, which involves the accumulation of fatty deposits, or plaques, within the walls of arteries. This causes them to narrow and harden, significantly reducing blood flow. PAD predominantly affects the legs, particularly the arteries supplying the thighs and calves. In rare cases, it may involve other arteries, including those in the arms.Etiology of PAD:The principal cause of PAD is atherosclerosis, which results from fatty...
79
Brainstem01:19

Brainstem

3.7K
The brainstem, located inferior to the brain and superior to the spinal cord, serves as a bridge between the cerebrum and the spinal cord. It plays a vital role in relaying information and controlling critical life functions. It comprises three primary regions: the midbrain, pons, and medulla oblongata.
The Midbrain
The midbrain is located beneath the diencephalon and connects the cerebrum with the lower parts of the brain. The cerebral peduncles are prominent midbrain structures that house the...
3.7K
Parkinson's Disease: Overview01:15

Parkinson's Disease: Overview

887
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
887
Parkinson's Disease: Treatment01:24

Parkinson's Disease: Treatment

469
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
469
Neural Regulation01:37

Neural Regulation

40.6K
Digestion begins with a cephalic phase that prepares the digestive system to receive food. When our brain processes visual or olfactory information about food, it triggers impulses in the cranial nerves innervating the salivary glands and stomach to prepare for food.
40.6K
Lysosomal Hydrolases01:22

Lysosomal Hydrolases

4.0K
Lysosomes are the site for the degradation of macromolecules and biological polymers released during membrane trafficking events such as secretory, endocytic, autophagic, and phagocytic pathways. The membrane-enclosed area of the lysosome, called the lumen, contains hydrolytic enzymes active in an acidic environment. These acid hydrolases are functional at a pH between 4.5 and 5 and are involved in cellular processes such as cell signaling, energy metabolism, restoration of the plasma membrane,...
4.0K

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

Cortical GABAergic dysfunction underlying abnormal hand movements in ARX mutation.

Clinical neurophysiology : official journal of the International Federation of Clinical Neurophysiology·2019
Same author

Gelastic Cataplexy in Niemann Pick Type C.

Movement disorders clinical practice·2019
Same author

The Interaction Between Neuroinflammation and β-Amyloid in Cognitive Decline in Parkinson's Disease.

Molecular neurobiology·2019
Same author

Tongue Protrusion Dystonia in Pantothenate Kinase-Associated Neurodegeneration.

Pediatric neurology·2019
Same author

Amantadine for Gait Dysfunction in Pantothenate Kinase-Associated Neurodegeneration.

The Canadian journal of neurological sciences. Le journal canadien des sciences neurologiques·2019
Same author

Deep brain stimulation in status dystonicus caused by anti-NMDA receptor encephalitis.

Parkinsonism & related disorders·2019

相关实验视频

Updated: Oct 22, 2025

Author Spotlight: Establishing a New Fluorescence-Based Protocol for In Vivo Mitochondrial Morphology Analysis in Parkinson's Disease
06:07

Author Spotlight: Establishing a New Fluorescence-Based Protocol for In Vivo Mitochondrial Morphology Analysis in Parkinson's Disease

Published on: June 23, 2023

1.8K

帕金森病是帕金森病的一种.

Lorraine V Kalia1, Anthony E Lang1

  • 1Morton and Gloria Shulman Movement Disorders Clinic and the Edmond J Safra Program in Parkinson's Disease, Toronto Western Hospital, Division of Neurology, Department of Medicine, University of Toronto, Toronto, ON, Canada.

Lancet (London, England)
|April 24, 2015
PubMed
概括

帕金森病 (PD) 呈现出复杂的运动和非运动症状,病理和未知的原因. 目前的治疗方法可以控制症状,但不能减缓神经退行,突出显著的临床挑战.

科学领域:

  • 神经学 神经学
  • 神经科学是一个神经科学.
  • 病理学 病理学 病理学

背景情况:

  • 帕金森病 (PD) 传统上是由运动症状,莱维体和 substantia nigra 神经元损失定义的.
  • 最近的理解揭示了PD的异质性,包括显著的非运动特征和超越莱维体的广泛病理.
  • 患病病因是多因素的,涉及影响细胞过程的遗传和环境因素之间的复杂相互作用.

研究的目的:

  • 审查帕金森病不断变化的复杂性.
  • 讨论与帕金森病诊断和管理相关的临床挑战.
  • 突出目前帕金森病治疗方法的局限性.

主要方法:

  • 关于帕金森病的文献综述.
  • 对目前对PD症状和病理学的理解进行分析.
  • 检查帕金森病的诊断和治疗挑战.

主要成果:

  • 帕金森病表现出异质的运动和非运动症状.
  • 病理超越黑体,涉及多个神经递质和蛋白质聚合物.
  • 早期诊断和有效的症状管理仍然具有挑战性,因为没有可用的疾病修饰治疗方法.

更多相关视频

Induction and Assessment of Levodopa-induced Dyskinesias in a Rat Model of Parkinson's Disease
05:51

Induction and Assessment of Levodopa-induced Dyskinesias in a Rat Model of Parkinson's Disease

Published on: October 14, 2021

4.0K
Behavioral Assessments of Spontaneous Locomotion in a Murine MPTP-induced Parkinson's Disease Model
05:38

Behavioral Assessments of Spontaneous Locomotion in a Murine MPTP-induced Parkinson's Disease Model

Published on: January 7, 2019

18.4K

相关实验视频

Last Updated: Oct 22, 2025

Author Spotlight: Establishing a New Fluorescence-Based Protocol for In Vivo Mitochondrial Morphology Analysis in Parkinson's Disease
06:07

Author Spotlight: Establishing a New Fluorescence-Based Protocol for In Vivo Mitochondrial Morphology Analysis in Parkinson's Disease

Published on: June 23, 2023

1.8K
Induction and Assessment of Levodopa-induced Dyskinesias in a Rat Model of Parkinson's Disease
05:51

Induction and Assessment of Levodopa-induced Dyskinesias in a Rat Model of Parkinson's Disease

Published on: October 14, 2021

4.0K
Behavioral Assessments of Spontaneous Locomotion in a Murine MPTP-induced Parkinson's Disease Model
05:38

Behavioral Assessments of Spontaneous Locomotion in a Murine MPTP-induced Parkinson's Disease Model

Published on: January 7, 2019

18.4K

结论:

  • 帕金森病是一种复杂的神经疾病,具有多方面的病理学和症状学.
  • 在早期诊断,症状管理和缺乏神经保护疗法方面存在重大临床挑战.
  • 需要进一步的研究来解开PD的复杂性,并开发有效的治疗方法.